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INTRODUCTION
The purpose of this study is to perform a randomized, double blind controlled trial to test the efficacy of Cognitive Behavioral Social Rhythm Therapy (CBSRT) in male veterans and activeduty personnel with PTSD, Major Depressive Disorder (MDD), and sleep or scheduling problems. CBSRT is designed to improve mood and sleep by stabilizing social rhythms (daily routine), increasing exposure to ambient light, changing dysfunctional bed/bedtime associations, activating the imagery system by changing nightmare content, and challenging dysfunctional automatic thoughts that might contribute to behavioral inactivation and nonadherence to the therapy protocol. CBSRT is hypothesized to facilitate readjustment by treating insomnia and stabilizing social rhythms, thereby leading to greater mood regulation abilities and eventual improvement in depression and posttraumatic stress disorder (PTSD) symptoms. To our knowledge, this project is the first to test a social rhythm therapy in a Veteran and PTSD population. This project is also the first to compare a behavioral sleep medicine group therapy to an active mental health group therapy condition. Present-Centered Therapy is an interpersonal and supportive group therapy based on approaches delineated by Irvin Yalom. 1 The specific aims of this project were as follows:
Specific Aim 1: To test whether group Cognitive Behavior Social Rhythm Therapy is superior to a control condition (present-centered therapy, PCT) in improving depression symptoms in patients with posttraumatic stress disorder, major depressive disorder, and sleep or social rhythm disturbances from baseline to the end of treatment and 6 months post-treatment. Specific Aim 2: To test whether group CBSRT is superior to PCT in improving sleep. Secondary Aim 3: To test whether CBSRT is superior to PCT in improving PTSD symptoms. Secondary Aim 4: To gather preliminary data evaluating CBSRT in veterans and active duty military personnel returning from Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF).
BODY
The following is a description of the research accomplishments associated with each task outlined in the approved Statement of Work: Task 1. Recruit 105 veterans with PTSD, MDD, and insomnia in order to have at least two observation points for 76 patients (38 in each group). Veterans will be randomly assigned into the CBSRT or active supportive group therapy control condition (present centered therapy, PCT) stratified upon the last era in which they were active duty military. At least 24 veterans (12 in each group) will have participated in Operation Iraqi Freedom (OIF) or Operation Enduring Freedom (OEF).
We completed 5 waves of group therapy. See Appendix A, Table 1 for overall enrollment figures. Our overall enrollment figure of 115 exceeded the goal of 105 enrolled participants outlined in our SOW (110%), with Human Research Protection Office (HRPO) approval to enroll up to 125 subjects as needed. However, despite this success we ultimately had a smaller number of eligible veterans who started therapy than expected (43 actual vs. 76 expected). The primary reason for this was a much higher overall screen fail rate (56.5% actual) than anticipated (28%) due in large part to absence of comorbid MDD, undetected sleep disorders, and recent medication changes. All veterans were required to be between the ages of 18 and 65. They were excluded for participation in shift work, recent alterations in medications, current substance abuse (< 30 days), uncontrolled medical illness, and severe traumatic brain injury/neurological disorder.
All participants were male Veterans with mean age of 48.42 years (SD = 13.51 years). Ethnicity distribution was 56% Caucasian, 23% Hispanic, 7% African Americian, 7% American Indian, 7% Other. Approximately 44% of subjects participated in the Vietnam War, 26% participated in OEF/OIF, and 30% participated in Desert Storm and other conflicts. There were no differences between groups on age or ethnicity. Randomization was stratified by military era (participation in OEF/OIF). Task 2. Perform reliable, double-blind assessments at baseline, throughout treatment, at posttreatment, and at 3 and 6 months after the conclusion of treatment (see Schedule of Assessments below).
As part of the research protocol, we developed an extensive, structured training program on outcomes measures that utilized a standardized definition of inter-rater reliability based on the Interclass Correlation Coefficient (ICC) > .80. See Appendix A, Table 2 for assessment dates and figures documenting study assessment activity. From baseline to the 6-month follow-up assessment, the project attrition rate was 27.9%. Task 3. Provide treatment while assuring therapist competence and fidelity We developed scales for competency and fidelity for both PCT and CBSRT, which included breakdowns for (1) therapy common factors and (2) unique therapy factors. All competency ratings were made by Drs. Haynes and Carlson. Therapy fidelity ratings were performed by Dr. Haynes, Dr. Carlson, and two advanced clinical psychology graduate students with specific training in group therapy. Both graduate students were trained by Drs. Haynes and Carlson and had high-levels of agreement with Drs. Haynes and Carlson on individual fidelity therapy item ratings (>85% items).
All therapy sessions were videotaped. We developed a standardized competency rating system that required therapists to demonstrate competency across two sessions of group therapy. In each wave of each condition, three group therapy sessions were randomly chosen to be rated for fidelity to treatment protocol (25% of all tapes were rated). Ratings indicated that therapists maintained adequate fidelity to proposed mechanisms of treatment.
See Appendix A, Table 3 for information about the provision of treatment.
CBSRT was associated with fewer therapy dropouts (χ 2 = 2.75, p < .10). Only 14% of the CBSRT group (n = 3) attended less than 75% sessions versus PCT, where 36% of the sample (n = 8) attended less than 75% of sessions. Individuals in CBSRT attended an average of 10 sessions (SD = 2.5), which was higher than those assigned to PCT (M = 8.36 sessions, SD = 3.54) via significant trend, F (1, 42) = 3.06, p <.10. Task 4. Analyze data, prepare manuscripts for publication and presentations at national conferences Major outcomes for the study were analyzed and presented at the Association for Professional Sleep Studies annual meeting in June 2012. Findings were as follows: Specific Aim 1: To test whether group Cognitive Behavior Social Rhythm Therapy is superior to a control condition (present-centered therapy, PCT) in improving depression symptoms in patients with posttraumatic stress disorder, major depressive disorder, and sleep or social rhythm disturbances from baseline to the end of treatment and 6 months post-treatment.
See Appendix A, Table 4 for depression outcomes. We found no statistically significant group differences between CBSRT v. PCT over time, although between-group effect size was smallmedium (d = .43). A trend (p < .10) indicated that both treatments resulted in improvements in depression symptoms (see Appendix A, Figure 1 ). From baseline to final assessment, 29% of CBSRT patients and 14% of PCT experienced a significant reduction in depression symptoms (≥ 50% drop on Hamilton Depression scores). Within-group effect sizes was large for CBSRT (d = 1.20) and moderate-large for PCT (d = 0.76).
Interpretation of these finding must be qualified by statistically significant differences in initial severity level, as individuals with CBSRT had significantly worse baseline symptoms. It must also be qualified for differential attrition. Although we performed intent-to-treat analyses with mixed modeling approaches, increased attrition in the PCT group may selectively bias the slope of change to benefit those who responded well to the therapy (especially for computation of the follow-up slope where these individuals did not possess a data point).
Specific Aim 2: To test whether group CBSRT is superior to PCT in improving sleep.
See Appendix A, Table 5 for daily sleep diary outcomes. During the treatment and follow-up periods, the rates of change in sleep efficiency (SE) in CBSRT v. PCT were significantly different (See Appendix A, Figure 2 ). Over the course of treatment, individuals in the CBSRT condition experienced an increase in sleep efficiency, unlike individuals in the PCT condition who experienced a decrease in sleep efficiency. In the follow-up period, there was a reversal in slope direction, with individuals in the CBSRT condition experiencing a minor decrease in SE and individuals in the PCT condition experiencing a minor increase in sleep efficiency. No other Condition x Time interactions emerged on other daily sleep diary indices. No significant changes occurred in total sleep time or wake time after sleep onset for either condition. Individuals in both conditions had a reduction in Time in Bed (TIB; average weekly decline by 6 minutes), a reduction in sleep onset latency (SOL; average weekly decline by approximately 2 minutes), and a reduction in the number of awakenings (see Appendix A, Figure 3 ). Improvements slowed in the follow-up period for both conditions; there was no significant Condition x PostTreatment interaction indicating no differential changes in slope post-treatment.
All findings must be qualified by initial differences in severity levels (worse sleep symptoms by individuals in CBSRT group) as well as differential attrition by condition (more drop-outs in PCT condition). Secondary Aim 3: To test whether CBSRT is superior to PCT in improving PTSD symptoms.
See Appendix A, Table 6 for PTSD outcomes. We found no statistically significant group differences between CBSRT v. PCT over time. Between-group effect size was negligible (d = .02). Significant main effects for time indicated that both group treatments results in significant PTSD symptom improvement (see Appendix A, Figure 4 ). Approximately 57% of patients in PCT group and 71% of patients in the CBSRT had a 10-point drop in CAPS scores (using difference between baseline and last completed assessment), suggesting that both groups were clinically effective. Within-group effect sizes were in the moderate to large range (d= .74 for CBSRT and d = .64 for PCT). Still, individuals in both groups had significant levels of residual PTSD symptoms (M 6-month CAPS score PCT group = 55.08, SD = 25.30; CBSRT group = 64 CAPS Score, SD = 19.48).
Interpretation of these finding must be qualified by statistically significant differences in initial severity level, as individuals with CBSRT had significantly worse baseline symptoms. It must also be qualified for differential attrition (increased attrition in PCT group). Secondary Aim 4: To gather preliminary data evaluating CBSRT in veterans and active duty military personnel returning from Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF).
While we had a lower than expected recruitment rate of OEF/OIF veterans, the distribution of OEF/OIF veterans in the sample used for analyses (i.e., randomized participants who started the therapy) is very close to our SOW projections (30.2% of the sample vs. the expected 32%). Therefore, the findings reported above are consistent with a representative veteran sample, including individuals who participated in OEF/OIF. No subset analyses were conducted given the inadequate power / instability associated with small sample of OEF/OIF veterans (13 total in both conditions).
Ancillary data analysis Several students have analyzed cross-sectional data associated with this project in order to increase our understanding of sleep disturbances in comorbid PTSD/MDD. First, we examined the relationship between PTSD symptoms, sleep, and mood regulation. Exploratory analyses indicated that poor concentration and irritability/anger each mediated the relationship between sleep and negative mood regulation (Kelly 2010) . Second, we used linear regression techniques to examine the relative contributions of PTSD vs. MDD symptoms as predictors of sleep disturbance. We found that PTSD symptoms scores were a better predictor of total sleep time (TST) than depression scores (β = -1.89, SE = .78, p < .05, Kelly 2011). Third, we examined nightly variation in actigraphic sleep parameters associated with SSRI use. Use of SSRIs was found to be associated with an increase in both the nightly variability of awakenings and percentage of time spent awake, suggesting that SSRIs might have a negative effect on patients' abilities to establish a routine sleep/wake pattern (Deoras 2010). Finally, we compared objective and subjective sleep indices and found a high correlation between total sleep time and wake time after sleep onset but a poor correlation between sleep onset latency, suggesting a misperception of the length of time to fall asleep (Kelly 2012 ).
Summary of data in relation to existing studies
To our knowledge, this is the first study to date comparing a group treatment that includes behavioral sleep medicine components to an active group mental health treatment designed to maximize interpersonal processes and support (consistent with Yalom-based model vs. education only). Moreover, this RCT is the first to provide a behavioral treatment to patients with both PTSD and MDD --two highly comorbid disorders 3, 4 that may be associated with worse outcomes than MDD alone. 5 Our findings suggested that both CBSRT and PCT improve sleep, although not to levels of complete insomnia remission. A number of studies suggest that CBT-I appears to be as effective for insomnia in the context of comorbid depression as in patients without comorbid depression when patients complete treatment.
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One study suggested that depression predicts drop-out of group This result suggests that our sleep-related outcomes may be slightly diminished by the use of intent-to-treat analyses. Further research is necessary utilizing intent-to-treat approaches with CBTi in severe mental illness.
While there may be some advantage to behavioral sleep interventions for sleep efficiency, overall findings suggest that active mental health treatments like PCT may also significantly improve sleep. These findings are consistent with secondary analyses from several RCTs examining sleep-outcomes for mental health treatments, like Cognitive Behavioral Therapy for Depression (CBT-D, individual format). Carney and colleagues 12 found that approximately one half of individuals with baseline sleep problems no longer experienced the relative sleep symptom after successful CBT-D. Of the successful CBT-D study patients, 13% experienced early insomnia, 14% middle insomnia, and 8% late insomnia. These rates were lower than those reported by Taylor and colleagues, 13 who found that 17%, 36%, and 24% of successful CBT -D responders continued to experience early, middle, and late insomnia, respectively. Interestingly, they also found that 29% of CBT-D responders continued to experience depressed mood and even more people continue to experience residual anxiety (37% experience psychological anxiety and 42% somatic anxiety). In the context of PTSD, Galovski 14 also found that CBT for PTSD significantly improved sleep, although substantial residual symptoms remained. Overall, these results suggest that insomnia is a symptom that is relatively responsive to treatments targeting mental health specifically. Our findings correspond to this report. However, it should be noted that none of the above studies examined group mental health treatments or utilized gold-standard daily sleep diary assessments.
Since the initiation of this project, several studies have employed group behavioral sleep treatments in Veterans with PTSD. Only one study has employed an active attention control condition; Cook and colleagues 15 compared group Imagery Rehearsal Therapy (IRT) to an active Sleep Education and Support condition in Vietnam Veterans with PTSD. Results were comparable to the current study, suggesting overall few differences in major outcomes of sleep, nightmare frequency, and also PTSD symptoms.
Overall, psychiatric outcome results are consistent with those from previous studies indicating limited treatment responsiveness for PTSD group therapies, especially for group therapies administered to Vietnam Veterans in a VA setting. 2 To our knowledge, only one previous randomized controlled trial (RCT) compared a cognitive behavioral group therapy to an attention control condition in outpatient Veterans with PTSD. In the largest and most rigorous study to date of group therapy for PTSD, Schnurr and colleagues 2 found no differences on PTSD or any other outcomes between Trauma-Focused Group Therapy (TFGT) and Present Centered Group Therapy. Individuals in both conditions experienced modest-sized pre-to post-treatment improvement in PTSD, which were maintained at 12 months. Several important distinctions exist in this study. First, neither condition in the current study focused on trauma. Second, the current sample would be considered a more severe subset of Veterans with PTSD, as all Veterans in the current study had both PTSD and current MDD compared to the Schnurr study where only 57% of the sample had current MDD. Third, the duration of treatment in this study was considerable shorter than the Schnurr study; treatment in this study lasted 12 weeks vs. 24 weeks in Schnurr study. As such, it is impressive to note that 71% of Veterans in CBSRT experienced a 10-point drop in CAPS score compared to TFGT (37.1% of TFGT group at 7-months post-treatment) and PCT (34.5% of Schnurr sample at 7-months post-treatment, 57% of our sample at 6-months posttreatment).
A significant trend indicated that individuals in the CBSRT were less likely to drop out of treatment (14% completed < 75% of sessions) than individuals in the PCT condition (36% completed < 75% of sessions). A 14% drop out rate is lower than rates reported by Schnurr for TFGT (22.8%) and lower than rates reported in individual CBT for PTSD (approximately 25%). It is unclear why our PCT noncompletion rate in our study (36%) was substantially higher than those previously reported by Schnurr (8.6%) . Further work is necessary in examining therapy dropout and in larger group therapy sample sizes.
Altogether, these data indicate that CBSRT may be a useful, adjunctive group therapy option for individuals with PTSD and MDD. Further studies are necessary to replicate findings, given the small sample size and low power to detect less-than large effects. Research is necessary to test whether present-focused group therapy options (such as PCT and CBSRT) improve exposure therapy outcomes.
KEY RESEARCH ACCOMPLISHMENTS
 CBSRT and PCT appear to produce comparable outcomes for both depression and PTSD, although effect size estimates indicate a small-moderate favor for CBSRT over PCT for depression.  Both CBSRT and PCT are associated with clinically significant improvements in depression and PTSD, though significant residual symptoms remain for the majority of veterans at the end of treatment.
 Both CBSRT and PCT are associated with a reduction of time in bed, sleep onset latency, and frequency of awakenings.  CBSRT is associated with faster improvements in sleep efficiency compared to PCT.  Neither CBSRT nor PCT were associated with significant improvements in total sleep time or wake time after sleep onset.  As compared to subjects in the PCT condition, subjects in CBSRT attended more therapy sessions and were less likely to drop-out of the active therapy component.
REPORTABLE OUTCOMES
The following are published abstracts and presentations over the course of this study which include data from this project (see "APPENDICES" for published abstracts). A manuscript describing major study outcomes is currently in preparation.
In Preparation Haynes, P., Kelly, M.R., Perkins, S., Parthasarathy, S., Schnurr, P., Shea, T., Bootzin, R. 
CONCLUSIONS
These data indicate that both CBSRT and PCT may be useful, adjunctive group therapy options for individuals with PTSD and MDD. Both forms of therapy are associated with significant levels of clinical improvement. As demonstrated by a lower attrition rate, CBSRT may be more acceptable or tolerable to patients than PCT. CBSRT may also have slight benefits over PCT in the improvement of depression and some sleep symptoms. Neither CBSRT nor PCT appear to treat PTSD, depression, or insomnia symptoms to levels of remission, thereby supporting DoD/VA Clinical Practice Guideline Review (2010) suggesting that group therapy for PTSD has overall limited treatment effectiveness. Nonetheless, group psychotherapies for PTSD are often employed in the VA system 16 in order to handle high demand for mental health services. Also, the group modality provides opportunities to receive therapeutic benefit from a number of nonspecific factors (e.g., expressiveness, 17 cohesion 1 ), which were not directly assessed as outcomes for the current study. Future work could benefit from the inclusion of outcomes that incorporate these factors, as well as ratings of patient acceptability and preference.
This study is the first randomized controlled therapy trial comparing a cognitive behavioral sleep treatment to an active mental health treatment condition in outpatient Veterans with both PTSD and MDD. The failure to find robust improvements in symptoms may relate to the chronic and severe nature of this comorbid population. The majority of participants in our study were taking psychotropic medications (74%) yet still meeting diagnostic criteria for study enrollment, thereby considered treatment nonresponders. Approximately 35% of our sample had a history of suicide attempt or psychiatric hospitalization. Our sample characteristics are consistent with previous studies indicating that patients with PTSD and MDD are more likely to have worse anxiety symptoms, Given the chronic and severe nature of the study population, sustained findings of clinical effectiveness may be significant, regardless of magnitude.
In addition, this is also the first RCT examining a social rhythm therapy in a group format and in a population of individuals with PTSD. As such, this project has provided valuable information that social rhythm therapies are feasible to administer to veterans with PTSD in a group format and are associated with clinical improvement.
Changes on Future Work Due to a higher than expected screen-fail rate, our study lacked statistical power to detect moderate effect sizes. Future studies could benefit from testing present-focused group cognitive behavioral therapies (such as CBSRT) utilizing a larger sample size. Moreover, it is recommended that future RCTs in this area utilize a randomization scheme that stratifies based on a composite score of initial symptom severity. Other recommendations for future work includes: (a) more treatments studies designed to targeting Veterans with comorbid PTSD and MDD, (b) inclusion of patient acceptability and preference measures in behavioral RCTs to assess potential reasons for differential attrition, (c) examination of differential therapy dosing schedules. In addition, future work could benefit from examining whether group therapies, such as CBSRT, improve response to PTSD exposure therapies.
Evaluating the Knowledge Overall, these findings are valuable in that they provide Veterans with comorbid PTSD and MDD an alternative, present-focused group therapy treatment option that (a) produces small to moderate improvements in PTSD and moderate improvements in depression and sleep and (b) appears to be well-tolerated as evidenced by a drop-out rate that is lower than PCT. These findings also contribute significantly to the literature base by supporting previous literature suggesting that group therapies for Veterans have overall limited treatment effectiveness for PTSD.
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Figure 1. Mean Hamilton Depression Rating Scores By Group Over Time
A compound symmetry variance matrix was used to model the error variance. PCGT is the reference condition. p < .10 CBSRT is an integrative group psychotherapy targeting both sleep and psychiatric symptoms via change of daytime and nighnime behavioral pattecns. PCGT is a well-established, interpersonal group therapy for PTSD that has previously been shown to have equal bendit as trauma-t-Ocused group therapy but with fewe r patient drop-outs. To our knowledge. this is the first randomized controlled group therapy trial comparing a behavioral sleep treat1nent to a well-researched mental health treatment in Veterans with PTSD and comorbid depression.
IX. Psychiatric and Behavioral Disorders and Sleep
Methods: Forty three male subjects (M age-48.81 years. SD-13A5 years) were assessed at baseline, 4 v .. •eeks. 8 weeks, post-t:reaunent. 3 months and 6 months post·treaunent. PTSD symptoms were assessed via the C linician Assessment of PTSD Scale (CAPS), and depression symptoms were assessed via the Hamilton Rating Scale for Depression. Mixed modeling was employed to examine preliminary diflCrences in trajectories across the course of therapy and at follow· up. Results: Preliminary intcnt-lo-treat analyses indicated that both therapies re.sulted in improvements in depression and clinically significant improvements in PTSD (> I 0 point drop on CAPS) with no differences between conditions. CBSRT was associated with fewer therapy dropouts (x'= 2.75, p < .10). Only 14% of the CBSRTgroup (n = 3) attended less than 75% sessions versus PCG·r~ whe-re 360./o or the sample attended less than 75% of sessions. Conclusion: CBSRT appears to be equivalent to PCGT on psychiatric outcomes. TI1is finding is similar to those from VA Cooperative Study 420 shO\ving the equivalency ofPCGTwith lr.. wma IOc.used group lhera~ py for PTSD.In the current trial, fewer participants appear to drop-out of CBSRT as compared to PCG1; suggesting that CBSRT may be a more acceptable group therapy th:lll PCGT for Veterans with PTSD. Analysis of sleep outcomes is pending. Support(! fAny): Depmtmento1Defense(Grant#W81XWH-08-2-0 12 1 ). Seventy-nine particip~mts "' 'ere randon1 lzed into the stud)'. Veterans were randomized to receive standard care (SC) only or SC plus MBSR. Intervention participants were provided with a take~home meditation module to use in between sessions. All participanlS completed an initial baseline asses,mcnt and 51 completed fi nal assessments lor PTSD as well as depression, pain! anxiety. stress and sleep. Veteran were assessed with the PTSD Check-List Military version (PCL-M). PIIQ-9. Beck Anxiety Inventory (BAI). visual analogue scale for pain. and tl1e PSQI. Re..sults: At baseline. , no dinCrcnccs were found for depression. anx i~ ety, pain or sleep. Both groups showed elevated levels of depression, m1xiety, pain and poor sleep quality. Compared to baseline, botl1 groups had reduced PTSD symptoms (p<.08), reduced depression symptoms (p<.OI5). and reduced perceived pain (p<.OOI). Aller controlling for age. baseline levels of PTSD. pain. depression. and length of time in treatment, a significant treatment x time etlect was tbund fbr Total Sleep Time (p=.039). The meditation intervention improved total sleep time independent of age. level ofPTSD pain or depression. Conclusion: MBSR may be an additional therapeutic tool that is easy to use and implement in existing treatment models. potentially improving the sleep of veterans with PTSD. Introduction: Actigraphy is a commonly used objective measurement of skcplwake outside tho lab. There is no consensus on the best method for scoring actigmphy. especially in populations with severe sleep disturbance. e.g .. Posttraumatic Stress Disorder (PTSD). Here. we compare three different scoring methods in Veterans with PTSD. Methods: 26 Veterans (age=35.6± 10.1yrs,5F) with PTSD and comorbid insomnia wore actigraphs and kept sleep dim·ies for one week. Actigraphy was scored using three methods: I) manufacturer de fault rest interval settings with automatic scoring (Automatic): 2) rest intervals set using Veterans' diary-reponed bed/wake times (Diary-Only): 3) diary-reponed times used as guidclinc.s, though rest intervals could be extended up to 60min on either side to account fOr obvious sleep outside diary-reponed (Diary+60). Time in bed (Till). total sleep time (TST). Wake Aller Sleep Onset (\VASO). and sleep efficiency (SE) were compared across methods. Results: TIB, TST, and SE diflered significantly among methods, though WASO did not. Automatic and Diary-Only produced equivalent TIB. while Diary+60 had longer TIB than both. Automatic est imated greater TST than Diary-Only and marginally greater TST than Diary+60 while Diary+60 estimated greater TST than Diary·Only. Automatic estimated higher SE than either Diat)' method. which we•· e equivalent. In tenns of clock times for the rest intervals_ Alltomatic was pha.o;.e·delayed vs Diary-Only for bed and wake time, and was phase-delayed vs Diary+60 for bedtime. Conclusion: The three scoring methods yielded very ditlerent estimates of s leep in Veterans with PTSD. Relative to Automatic default senings, using Diary times 10 set rest intervals reduced TST and SE. Using modified Diary+60 rest intervals increased TIB and TST. and reduced SE. Importantly. rest interval clock times diflered by 28-40min runong the methods. Automatic misses SL, atld thus over-estimates SE. TI•ese dis-
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